224 related articles for article (PubMed ID: 32285579)
41. Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina.
Gomez SM; Caniza M; Fynn A; Vescina C; Ruiz CD; Iglesias D; Sosa F; Sung L
Transpl Infect Dis; 2018 Aug; 20(4):e12913. PubMed ID: 29679436
[TBL] [Abstract][Full Text] [Related]
42. Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation.
Linke C; Ehlert K; Ahlmann M; Fröhlich B; Mohring D; Burkhardt B; Rössig C; Groll AH
Mycoses; 2020 Feb; 63(2):172-180. PubMed ID: 31661569
[TBL] [Abstract][Full Text] [Related]
43. Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.
Phillips GL; Meisenberg BR; Reece DE; Adams VR; Badros AZ; Brunner JL; Fenton RG; Filicko J; Grosso DL; Hale GA; Howard DS; Johnson VP; Kniska A; Marshall KW; Mookerjee B; Nath R; Rapoport AP; Sarkodee-Adoo C; Takebe N; Vesole DH; Wagner JL; Flomenberg N
Bone Marrow Transplant; 2004 Apr; 33(8):781-7. PubMed ID: 14767498
[TBL] [Abstract][Full Text] [Related]
44. [Outcome of haploidentical hematopoietic stem cell transplantation for non-Hodgkin lymphoma].
Xu T; Chen J; Jin ZM; Miao M; Fu CC; Qiu HY; Tang XW; Han Y; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):656-60. PubMed ID: 27587245
[TBL] [Abstract][Full Text] [Related]
45. Comparison of Various Hematopoietic Stem Cell Mobilization Regimens in Patients with Lymphoma and Myeloma.
Yilmaz Ü; Salim O; Yücel OK; Iltar U; Ündar L
Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625348
[TBL] [Abstract][Full Text] [Related]
46. The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B-cell non-Hodgkin lymphoma and mature B-cell leukemia: a retrospective analysis of enrolled cases in Japan.
Fujita N; Mori T; Mitsui T; Inada H; Horibe K; Tsurusawa M;
Pediatr Blood Cancer; 2008 Aug; 51(2):188-92. PubMed ID: 18428432
[TBL] [Abstract][Full Text] [Related]
47. Changes in the epidemiology of invasive fungal disease in a Pediatric Hematology and Oncology Unit: the relevance of breakthrough infections.
Calle-Miguel L; Garrido-Colino C; Santiago-García B; Moreno Santos MP; Gonzalo Pascual H; Ponce Salas B; Beléndez Bieler C; Navarro Gómez M; Guinea Ortega J; Rincón-López EM
BMC Infect Dis; 2023 May; 23(1):348. PubMed ID: 37226103
[TBL] [Abstract][Full Text] [Related]
48. Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.
Vose JM; Rizzo DJ; Tao-Wu J; Armitage JO; Bashey A; Burns LJ; Christiansen NP; Freytes CO; Gale RP; Gibson J; Giralt SA; Herzig RH; Lemaistre CF; McCarthy PL; Nimer SD; Petersen FB; Schenkein DP; Wiernik PH; Wiley JM; Loberiza FR; Lazarus HM; van Biesen K; Horowitz MM
Biol Blood Marrow Transplant; 2004 Feb; 10(2):116-27. PubMed ID: 14750077
[TBL] [Abstract][Full Text] [Related]
49. A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation.
Taçyıldız N; Tanyıldız HG; Ünal E; Dinçaslan H; Asarcıklı F; Aksoy BA; Vatansever G; Yavuz G
Turk J Pediatr; 2019; 61(5):671-676. PubMed ID: 32104998
[TBL] [Abstract][Full Text] [Related]
50. Infections diagnosed in the first year after pediatric stem cell transplantation.
Benjamin DK; Miller WC; Bayliff S; Martel L; Alexander KA; Martin PL
Pediatr Infect Dis J; 2002 Mar; 21(3):227-34. PubMed ID: 12005087
[TBL] [Abstract][Full Text] [Related]
51. Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation.
Manson G; Mear JB; Herbaux C; Schiano JM; Casasnovas O; Stamatoullas A; Deau B; Schmitt A; Garnier G; Regny C; Bouabdallah K; Moles-Moreau MP; Ghesquieres H; Tempescul A; Dulery R; Nicolas-Virelizier E; Delmer A; Borel C; Chauchet A; Damotte D; Dercle L; Brice P; Houot R;
Eur J Cancer; 2019 Jul; 115():47-56. PubMed ID: 31082693
[TBL] [Abstract][Full Text] [Related]
52. Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma-Polish Lymphoma Research Group real-life analysis.
Długosz-Danecka M; Hus I; Puła B; Jurczyszyn A; Chojnacki T; Blajer-Olszewska B; Drozd-Sokołowska J; Raźny M; Romejko-Jarosińska J; Taszner M; Jurczak W
Pharmacol Rep; 2019 Jun; 71(3):473-477. PubMed ID: 31003160
[TBL] [Abstract][Full Text] [Related]
53. Birth characteristics and risk of lymphoma in young children.
Marcotte EL; Ritz B; Cockburn M; Clarke CA; Heck JE
Cancer Epidemiol; 2014 Feb; 38(1):48-55. PubMed ID: 24345816
[TBL] [Abstract][Full Text] [Related]
54. Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma.
Herrera AF; Chen L; Khajavian S; Chase M; Darrah J; Maloney D; Ho VT; Soiffer RJ; Antin JH; Forman SJ; Nademanee AP; Chen YB; Armand P; Shadman M
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2383-2387. PubMed ID: 31394277
[TBL] [Abstract][Full Text] [Related]
55. High dose chemotherapy and autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: Emerging questions, newer agents, and changing paradigm.
Akhtar S
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):272-276. PubMed ID: 28641095
[TBL] [Abstract][Full Text] [Related]
56. Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.
Zwitserloot AM; Mavinkurve-Groothuis AM; Galama JM; Verweij PE; Hoogerbrugge PM; Warris A
Scand J Infect Dis; 2012 May; 44(5):355-62. PubMed ID: 22216875
[TBL] [Abstract][Full Text] [Related]
57. Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.
Nademanee A; Molina A; Dagis A; Snyder DS; O'Donnell MR; Parker P; Stein A; Smith E; Planas I; Kashyap A; Spielberger R; Fung H; Krishnan A; Bhatia R; Wong KK; Somlo G; Margolin K; Chow W; Sniecinski I; Vora N; Slovak M; Niland JC; Forman SJ
Clin Lymphoma; 2000 Jun; 1(1):46-54. PubMed ID: 11707813
[TBL] [Abstract][Full Text] [Related]
58. Leukemia and lymphoma incidence in children in Alberta, Canada: a population-based 22-year retrospective study.
Kulkarni K; Stobart K; Witol A; Rosychuk RJ
Pediatr Hematol Oncol; 2011 Nov; 28(8):649-60. PubMed ID: 21981741
[TBL] [Abstract][Full Text] [Related]
59. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology.
Won SC; Han JW; Kwon SY; Shin HY; Ahn HS; Hwang TJ; Yang WI; Lyu CJ
Ann Hematol; 2006 Nov; 85(11):787-94. PubMed ID: 16932891
[TBL] [Abstract][Full Text] [Related]
60. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
